Hiv Drugs
May 28, 2012 at 14:34 | Source: Moneycontrol.com
May 23, 2012 at 12:21 | Source: Moneycontrol.com
May 04, 2012 at 13:45 | Source: CNBC-TV18
May 04, 2012 at 09:25 | Source: Moneycontrol.com
Apr 17, 2012 at 08:32 | Source: Reuters
Mar 13, 2012 at 16:06 | Source: Reuters
News across the web »
May 17, 2012 at 17:55 | Source: The Hindu BusinessLine
May 16, 2012 at 14:00 | Source: NDTV Profit
May 14, 2012 at 20:37 | Source: Money Rediff News Report
May 14, 2012 at 08:27 | Source: Economic Times
May 14, 2012 at 01:01 | Source: Business Standard
Interact & exchange stock tips & market info »
Related News »
The outlook for Gilead Sciences (NASDAQ:GILD) brightened substantially last week. A U.S. government advisory panel recommended approval of Quad, the company’s experimental four-in-one HIV drug, and the off-label use of Truvada, an existing ...
May 17, 2012 at 13:57 | Source: Investorplace.com
Common sense suggests that in a time of wringing blood from turnips, every member of the U.S. Congress would leap at the chance to save the nation billions of dollars. Yet Sen. Bernie Sanders (I-Vt.), the most commonsensical man on Capitol Hill, was the ...
May 17, 2012 at 16:34 | Source: Huffington Post
Because drug manufacturers waive their patent rights in developing nations in compliance with the President’s Emergency Fund for AIDS Relief, Americans have paid tens of thousands for the same HIV drugs that cost hundreds of dollars in Africa.
May 15, 2012 at 12:33 | Source: Think Progress
An estimated 1.2 million Americans have HIV, which attacks the immune system and, unless treated with antiviral drugs, develops into AIDS, a fatal condition in which the body cannot fight off infections. If Truvada is approved, it would be a ...
May 8, 2012 at 22:07 | Source: msnbc.com
The team examined data from the Development of AntiRetroviral Therapy of Africa (DART) trial in order to determine what affect Antiretroviral therapy (ART - a combination of anti-HIV drugs) had on infants born to Ugandan and Zimbabwean HIV ...
May 15, 2012 at 20:55 | Source: Medical News Today
Washington, D.C. - infoZine - Scripps Howard Foundation Wire - Sen. Bernard Sanders, I–Vt., chairman of the subcommittee on Primary Health and Aging of the Health, Education, Labor and Pensions Committee, held a hearing Tuesday to discuss his proposal to ...
May 16, 2012 at 13:22 | Source: Kansas City infoZine
WASHINGTON -- FDA advisory committees this week endorsed two new HIV drugs and an arthritis drug, and rejected an application for an investigational gout treatment. Meanwhile, the Centers for Medicare and Medicaid Services announced a two-year ...
May 12, 2012 at 14:53 | Source: MedPage Today
Most of the women who became pregnant were taking a tenofovir-containing combination of anti-HIV drugs before and throughout their pregnancies and out of the 226 live births, the researchers recorded that there was no increase in the proportion ...
May 15, 2012 at 20:47 | Source: medicalxpress.com
With drug patent expirations approaching in the next several years, Gilead would be able to extend market exclusivity for an HIV treatment with Quad, he notes. Quad is made up two older Gilead drugs -- Viread and Emtriva -- and a couple of ...
May 14, 2012 at 14:51 | Source: Minyanville
(RTTNews) - Gilead Sciences Inc. (GILD: News ) Friday said that its experimental drug for treating HIV, known as Quad, won the backing of an FDA advisory panel. The Antiviral Drugs Advisory Committee voted 13 to 1 in favor of Quad to treat HIV-1 infection ...
May 11, 2012 at 22:18 | Source: RTT News